Distinctions and contradistinctions between antiobesity histamine H3 receptor (H3R) antagonists compared to cognition-enhancing H3 receptor antagonists

被引：9

作者：

Hancock, A. A. ^{[1
]}

Bitner, R. S. ^{[1
]}

Krueger, K. M. ^{[1
]}

Otte, S. ^{[1
]}

Nikkel, A. L. ^{[1
]}

Fey, T. A. ^{[1
]}

Bush, E. N. ^{[1
]}

Dickinson, R. W. ^{[1
]}

Shapiro, R. ^{[1
]}

Knourek-Segel, V. ^{[1
]}

Droz, B. A. ^{[1
]}

Brune, M. E. ^{[1
]}

Jacobson, P. B. ^{[1
]}

Cowart, M. D. ^{[1
]}

Esbenshade, T. A. ^{[1
]}

机构：

[1] Abbott Labs, Dept R4MN, Abbott Pk, IL 60064 USA

来源：

INFLAMMATION RESEARCH | 2006年 / 55卷 / Suppl 1期

关键词：

.;

D O I：

10.1007/s00011-005-0034-0

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 [细胞生物学]; 090102 [作物遗传育种];

摘要：

.

引用

收藏

页码：S42 / S44

页数：3

相关论文

共 7 条

[1]

Role of the nucleus raphe magnus in antinociception produced by ABT-594: Immediate early gene responses possibly linked to neuronal nicotinic acetylcholine receptors on serotonergic neurons [J].

Bitner, RS ;

Nikkel, AL ;

Curzon, P ;

Arneric, SP ;

Bannon, AW ;

Decker, MW .

JOURNAL OF NEUROSCIENCE, 1998, 18 (14) :5426-5432

[2]

Two novel and selective nonimidazole histamine H3 receptor antagonists A-304121 and A-317920:: I.: In vitro pharmacological effects [J].

Esbenshade, TA ;

Krueger, KM ;

Miller, TR ;

Kang, CH ;

Denny, LI ;

Witte, DG ;

Yao, BB ;

Fox, GB ;

Faghih, R ;

Bennani, YL ;

Williams, M ;

Hancock, AA .

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 305 (03) :887-896

[3]

Antiobesity evaluation of histamine H3 receptor (H3R) antagonist analogs of A-331440 with improved safety and efficacy [J].

Hancock, AA ;

Diehl, MS ;

Fey, TA ;

Bush, EN ;

Faghih, R ;

Miller, TR ;

Krueger, KM ;

Pratt, JK ;

Cowart, MA ;

Dickinson, RW ;

Shapiro, R ;

Knourek-Segel, VE ;

Droz, BA ;

McDowell, CA ;

Krishna, G ;

Brune, ME ;

Esbenshade, TA ;

Jacobson, PB .

INFLAMMATION RESEARCH, 2005, 54 (Suppl 1) :S27-S29

[4]

Assessment of pharmacology and potential anti-obesity properties of H3 receptor antagonists/inverse agonists [J].

Hancock, AA ;

Brune, ME .

EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2005, 14 (03) :223-241

[5]

Perspectives on cognitive domains, H3 receptor ligands and neurological disease [J].

Hancock, AA ;

Fox, GB .

EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2004, 13 (10) :1237-1248

[6]

Genetic and pharmacological aspects of histamine H3 receptor heterogeneity [J].

Hancock, AA ;

Esbenshade, TA ;

Krueger, KM ;

Yao, BB .

LIFE SCIENCES, 2003, 73 (24) :3043-3072

[7]

YATES SL, 2003, AM CHEM SOC, P2